Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Explore wealth management tips tailored to high income individuals, emphasizing diversified investments and efficient tax planning.
26,310 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Kratos Defense stock keeps facing pressure after announcing a sizable stock sale. This guide breaks down dilution, it...
BioNTech’s stock is under pressure as investors react to weak guidance and leadership pivots. This deep dive breaks d...
Dlocal is navigating a fast-changing cross-border payments landscape in 2025. This guide breaks down the key drivers,...
Intel posted a stronger-than-expected Q1, yet rising costs and cash-flow strain raise the risk of a sharper pullback....
Figma stunned traders with a big Q1 2026 beat, lifting the stock on Friday morning. Here’s what happened, why it matt...
Marvell Technology’s stock seesaws as AI demand accelerates its growth outlook, even as investors weigh cyclical chip...
An overlooked defense contractor pivots to AI, turning years of skepticism into a rising star in enterprise AI and de...
Striking the right balance between steady index exposure and selective stock bets can power long-term gains. Explore ...
ON Semiconductor rides AI data-center demand and EV silicon trends to extend its rally, but analysts warn that valuat...
Garmin stock soared this week after the GPS giant posted a solid Q4 and guided higher for 2026. This article breaks d...
Lighter’s upgraded liquidity framework held firm during a $50 million ARC perpetual squeeze, enforcing a $75,000 cap ...